Clinical Trial Update: Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant mFOLFOXIRI plus cadonilimab (AK104) versus mFOLFOX6 in locally advanced colorectal cancer; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cadonilimab (AK104) (Cadonilimab)
• MFOLFOXIRI

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING